Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $789,287 - $863,610
1,936 Added 48.79%
5,904 $2.47 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $840,007 - $1.01 Million
2,449 Added 161.22%
3,968 $1.61 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $513,695 - $550,576
1,519 New
1,519 $528,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $13.6 Million - $15.5 Million
-48,044 Reduced 92.0%
4,176 $1.32 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $6.58 Million - $7.41 Million
23,040 Added 78.96%
52,220 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $7.99 Million - $8.92 Million
29,180 New
29,180 $8.45 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $2.67 Million - $3.37 Million
-15,061 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $2.73 Million - $3.06 Million
15,061 New
15,061 $2.73 Million
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $3.87 Million - $5.17 Million
-18,712 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$255.65 - $303.1 $2.1 Million - $2.49 Million
8,206 Added 78.11%
18,712 $5.09 Million
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $868,323 - $1.14 Million
-3,851 Reduced 26.82%
10,506 $3.05 Million
Q1 2020

May 08, 2020

SELL
$199.77 - $247.81 $2.62 Million - $3.25 Million
-13,134 Reduced 47.78%
14,357 $3.42 Million
Q4 2019

Feb 12, 2020

BUY
$166.71 - $223.91 $1.54 Million - $2.07 Million
9,262 Added 50.81%
27,491 $6.02 Million
Q3 2019

Nov 08, 2019

BUY
$166.23 - $187.09 $1.5 Million - $1.69 Million
9,027 Added 98.1%
18,229 $3.09 Million
Q2 2019

Aug 09, 2019

SELL
$164.61 - $190.37 $2.43 Million - $2.81 Million
-14,745 Reduced 61.57%
9,202 $1.69 Million
Q1 2019

May 13, 2019

BUY
$163.73 - $194.7 $3.92 Million - $4.66 Million
23,947 New
23,947 $4.41 Million
Q4 2018

Feb 13, 2019

SELL
$151.91 - $192.21 $1.01 Million - $1.28 Million
-6,646 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$167.73 - $192.74 $3.81 Million - $4.38 Million
-22,733 Reduced 77.38%
6,646 $1.28 Million
Q2 2018

Aug 07, 2018

BUY
$145.72 - $169.96 $743,317 - $866,965
5,101 Added 21.01%
29,379 $4.99 Million
Q1 2018

May 03, 2018

BUY
$151.6 - $177.13 $3.68 Million - $4.3 Million
24,278 New
24,278 $3.96 Million
Q4 2017

Feb 09, 2018

SELL
$137.28 - $155.55 $777,553 - $881,035
-5,664 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$148.13 - $162.24 $839,008 - $918,927
5,664
5,664 $861,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.